Journals / Eurasian Journal of Pulmonology / 2021 / Cilt: 23 - Sayı: 3

A case of immunoglobulin G4‑related lung disease with normal serum immunoglobulin G4 level and hybrid radiological findings

Pages
191–194
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here, we present a patient, with normal serum IgG4 level, acute-subacute respiratory symptoms, extensive parenchymal consolidation in chest computed tomography, and intensive IgG4‑positive‑lymphoplasmocytic‑infiltration in lung biopsy and the result of 6-month methylprednisolone and methotrexate treatment for IgG4-related lung disease.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pulmonary involvement in immunoglobulin (Ig) G4-related disease is very rare and usually in the form of parenchymal infiltrates.
📊
Key Findings & Data:Symptoms vary according to the location and severity of the infiltration.
💡
Conclusion & Impact:Here, we present a patient, with normal serum IgG4 level, acute-subacute respiratory symptoms, extensive parenchymal consolidation in chest computed tomography, and intensive IgG4‑positive‑lymphoplasmocytic‑infiltration in lung biopsy and the result of 6-month methylprednisolone and methotrexate treatment for IgG4-related lung disease.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Pulmonary involvement in immunoglobulin (Ig) G4-related disease is very rare and usually in the form of parenchymal infiltrates. Symptoms vary according to the location and severity of the infiltration. Previously, the radiological findings were categorized as solid nodule or mass, ground‑glass opacity, interlobular septal, or bronchovascular bundle thickening. However, in some patients, all forms of radiological findings present at the same time. We do not know whether it is a type of disease or whether there is a difference in the disease course. Here, we present a patient, with normal serum IgG4 level, acute-subacute respiratory symptoms, extensive parenchymal consolidation in chest computed tomography, and intensive IgG4‑positive‑lymphoplasmocytic‑infiltration in lung biopsy and the result of 6-month methylprednisolone and methotrexate treatment for IgG4-related lung disease.

🔖

Cite This Article

YAZISIZ, V., DİROL, H., ÖZBUDAK, İ. H. (2022). A case of immunoglobulin G4‑related lung disease with normal serum immunoglobulin G4 level and hybrid radiological findings. Eurasian Journal of Pulmonology, Cilt: 23 - Sayı: 3, 191–194. https://ajindex.com/articles/509566

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (10)

  1. Hamano H, Kawa S, Horiuchi A, Unno H, Furuya N, Akamatsu T, et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001;344:732‑8
  2. Okazaki K, Umehara H. Current concept of IgG4‑related disease. Curr Top Microbiol Immunol 2017;401:1‑17
  3. Kamisawa T, ZenY, Pillai S, Stone JH. IgG4‑related disease. Lancet 2015;385:1460‑71
  4. Khosroshahi A, Stone JH. A clinical overview of IgG4‑related systemic disease. Curr Opin Rheumatol 2011;23:57‑66
  5. Ryu JH, Sekiguchi H, Yi ES. Pulmonary manifestation of immunoglobulin G4‑relating sclerosing disease. Eur Respir J 2012;39:180‑6
  6. Carruthers MN, Khosroshahi A, Augustin T, Deshpande V, Stone JH. The diagnostic utility of serum IgG4 concentrations in IgG4‑related disease. Ann Rheum Dis 2015;74:14‑8
  7. Masaki Y, Kurose N, Yamamoto M, Takahashi H, Saeki T, Azumi A, et al. Cutoff values of serum IgG4 and histopathological IgG4+plasma cells for diagnosis of patients with IgG4‑related disease. Int J Rheumatol 2012;2012:580814
  8. Inoue D, Zen Y, Abo H, Gabata T, Demachi H, Kobayashi T, et al. Immunoglobulin G4‑related lung disease: CT findings with pathologic correlations. Radiology 2009;251:260‑70
  9. Zhou J, Li X, Zeng Q. IgG4‑related lung disease with atypical CT imaging: A case report. J Thorac Dis 2014;6:E276‑80
  10. Khan ML, Colby TV, Viggiano RW, Fonseca R. Treatment with bortezomib of a patient having hyper IgG4 disease. Clin Lymphoma Myeloma Leuk 2010;10:217‑9.